一种传播到全球的流感新变种正在推动美国和台湾出现病例,但疫苗仍能防止严重的后果。 A new flu variant spreading globally is driving cases in the U.S. and Taiwan, but vaccines still prevent severe outcomes.

甲型H3N2流感亚Clade K变种目前在台湾占据主导地位,并遍及全球,占台湾病例的90%以上,占美国病例的一半以上,与2025-2026年疫苗相比,传染性和遗传差异有所增加。 The H3N2 flu subclade K variant, now dominant in Taiwan and spreading globally, accounts for over 90% of cases there and more than half in the U.S., with increased transmissibility and genetic differences from the 2025-2026 vaccine. 虽然预防感染的疫苗保护可能减少,但它在预防严重疾病、住院和死亡方面仍然有效。 While vaccine protection against infection may be reduced, it remains effective in preventing severe illness, hospitalization, and death. 台湾流感季节提前达到高峰,但在政府接种疫苗运动后却有所下降,预计月球新年可能会再度爆发。 Taiwan’s flu season peaked early but declined after a government vaccination campaign, with a potential resurgence expected around the Lunar New Year. 健康官员敦促美国人接种疫苗,特别是在假期旅行增加和疫苗接种率低的情况下。 Health officials urge Americans to get vaccinated, especially amid rising holiday travel and low vaccination rates.